Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEDCAN CC01
- Development stage
- Unknown
- Lead developer
- Medcan Australia
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation
01
Overview
MEDCAN CC01 is a medical cannabis product developed by Medcan Australia. It is a high-THC, indica-dominant dried flower cultivar derived from the Cold Creek Kush (also known as Afghan Kush) strain, which is a genetic cross between MK Ultra and Chemdawg 91. The product typically contains approximately 21% to 22% tetrahydrocannabinol (THC) and minimal cannabidiol (CBD < 1%). It is prescribed in Australia via the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) and Authorised Prescriber (AP) pathways for the management of conditions such as chronic pain, insomnia, anxiety, muscle spasms, and chronic stress.
- Brand names
- MEDCAN CC01
- Other names
- Afghan KushCold Creek KushMEDCAN CC01-V
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on MEDCAN CC01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEDCAN CC01.